2020 ASCO Virtual Direct™ Highlights

 

2020 ASCO Virtual Direct™ Highlights
Avatar

2020 ASCO Update on Delivery of ADT in Advanced Prostate Cancer: Relugolix vs. Leuprolide Acetate - Which Option Is Superior?

By 2020 ASCO Virtual Direct™ Highlights FEATURING Hala Borno
By 2020 ASCO Virtual Direct™ Highlights FEATURING Hala Borno
120 views
August 24, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay

Featured Video

20:09
AstraZeneca Oncology

Management Strategies for Anemia in First-line Maintenance Therapy f…

Feat. D. Czel, C. Arn
GU
08:02
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on mUC: Can Tumor Microenvironment Biomarkers Help …

Feat. D. Quinn
06:18
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Advanced RCC: Is Nivo Monotherapy Active in Trea…

Feat. D. Quinn
09:35
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Advanced RCC: 1L Pembro + Axitinib vs. Sunitinib…

Feat. D. Quinn
10:31
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Advanced Urothelial Cancer: Maintenance Avelumab…

Feat. D. Quinn
09:43
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Delivery of ADT in Advanced Prostate Cancer: Rel…

Feat. H. Borno
08:38
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Molecular Imaging in Prostate Cancer: Is 18F-DCF…

Feat. H. Borno
09:15
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on nmCRPC: Does the Utilization of Early AR Antagon…

Feat. H. Borno